09:34:22 EDT Wed 22 Jul 2026
Enter Symbol
or Name
USA
CA



CME Group Inc. Reports Strong Financial Results for Q2 2026

2026-07-22 07:00 ET - News Release

CME Group Inc. Reports Strong Financial Results for Q2 2026

PR Newswire

CHICAGO, July 22, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2026.

The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2026. Net income was $1.0 billion and diluted earnings per common share were $2.88. On an adjusted basis, operating income was $1.2 billion, net income was $1.1 billion and diluted earnings per common share were $2.99. Financial results presented on an adjusted basis for the second quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1

"The first half of 2026 was the strongest in CME Group's history," said CME Group Chairman and Chief Executive Officer Terry Duffy. "We delivered record H1 performance across revenue, adjusted operating income, adjusted net income and adjusted earnings per share, all of which were powered by record trading in Q1 and our second-highest Q2 volumes ever. During Q2, market data revenue increased 20% to a record $238 million. Importantly, we provided more than $95 billion in daily margin efficiencies during the quarter, a new high that represents unparalleled capital savings that our clients can redeploy in their businesses. We also continue to innovate a number of new tools to help clients manage risk and pursue opportunities, including Single-Stock futures, 1-Ounce Gold contracts available 24/7, U.S. Treasury clearing and Compute futures."

Second-quarter 2026 average daily volume (ADV) was the third highest quarterly ADV reaching 29.8 million contracts, which included non-U.S. ADV of 9.1 million contracts.

Clearing and transaction fees revenue for second-quarter 2026 totaled $1.4 billion. The total average rate per contract was $0.678. Market data revenue totaled a record $238 million for second-quarter 2026.


 
 1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Earnings per Common Share charts at the end of the financial statements.

As of June 30, 2026, the company had $2.3 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the second quarter of approximately $468 million and repurchased $695 million in CME Group common shares.

CME Group will hold a Q&A conference call to discuss second-quarter 2026 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.comunder Events & Presentations. An archived recording will be available for up to two months after the call.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data - empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange,cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

Statements in this press release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs associated with CME Group's transition to the Google Cloud, and minimize duplicative costs of maintaining both on-premise and Google Cloud environments during the transition; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors, futures commission merchants, introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments, alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk Factors".

                                                    
          
     CME Group Inc. and Subsidiaries


                                                      
          
     Consolidated Balance Sheets


                                                                   
    (in millions)




                                                                                                     June 30, 2026 December 31, 2025



 ASSETS



 Current Assets:



 Cash and cash equivalents                                                                               $2,144.2           $4,416.9



 Marketable securities                                                                                      131.4              125.0



 Accounts receivable, net of allowance                                                                      753.1              639.2



 Other current assets (includes $4.4 and $6.5 in restricted cash)                                           491.7              522.1



 Performance bonds and guaranty fund contributions                                                      158,110.7          159,656.1



 Total current assets                                                                                   161,631.1          165,359.3



 Property, net of accumulated depreciation and amortization                                                 351.2              362.7



 Intangible assets-trading products                                                                      17,175.3           17,175.3



 Intangible assets-other, net                                                                             2,494.6            2,610.7



 Goodwill                                                                                                10,505.8           10,514.7



 Other assets                                                                                             2,518.6            2,401.5



 Total Assets                                                                                          $194,676.6         $198,424.2



 LIABILITIES AND EQUITY



 Current Liabilities:



 Accounts payable                                                                                           $68.0              $71.8



 Other current liabilities                                                                                  538.6              568.8



 Performance bonds and guaranty fund contributions                                                      158,110.7          159,656.1



 Total current liabilities                                                                              158,717.3          160,296.7



 Long-term debt                                                                                           3,424.2            3,422.3



 Deferred income tax liabilities, net                                                                     5,220.9            5,242.2



 Other liabilities                                                                                          793.8              734.8



 Total Liabilities                                                                                      168,156.2          169,696.0



 Total CME Group Shareholders' Equity                                                                    26,520.4           28,728.2



 Total Liabilities and Equity                                                                          $194,676.6         $198,424.2

                                                      
          
            CME Group Inc. and Subsidiaries


                                                     
          
            Consolidated Statements of Income


                                          
          (dollars in millions, except per share amounts; shares in thousands)




                                                                                                                                         Quarter Ended                          Six Months Ended

                                                                                                                                         June 30,                          June 30,


                                                                                                                              2026       2025              2026         2025



          
            Revenues



          Clearing and transaction fees                                                                                  $1,352.5   $1,388.0          $2,895.1     $2,725.3



          Market data and information services                                                                              238.1      198.1             462.2        392.6



          Other                                                                                                             115.6      105.9             229.0        216.4



          
            Total Revenues                                                                                     1,706.2    1,692.0           3,586.3      3,334.3



          
            Expenses



          Compensation and benefits                                                                                         233.5      221.6             456.5        428.3



          Technology                                                                                                         83.3       70.9             159.9        136.6



          Professional fees and outside services                                                                             29.1       37.4              57.3         65.9



          Amortization of purchased intangibles                                                                              56.0       56.1             112.1        111.3



          Depreciation and amortization                                                                                      28.2       27.3              55.4         54.6



          Licensing and other fee agreements                                                                                109.1       96.2             215.9        192.8



          Other                                                                                                              59.9       53.2             112.4        107.5



          
            Total Expenses                                                                                       599.1      562.7           1,169.5      1,097.0



          
            Operating Income                                                                                   1,107.1    1,129.3           2,416.8      2,237.3



          
            Non-Operating Income (Expense)



          Investment income                                                                                               1,429.7    1,518.4           2,819.0      2,411.1



          Interest and other borrowing costs                                                                               (43.6)    (44.0)           (87.2)      (85.7)



          Equity in net earnings of unconsolidated subsidiaries                                                              97.7       99.0             200.1        187.2



          Other non-operating income (expense)                                                                          (1,263.2) (1,372.4)        (2,510.1)   (2,174.8)



          
            Total Non-Operating Income (Expense)                                                                 220.6      201.0             421.8        337.8



          
            Income before Income Taxes                                                                         1,327.7    1,330.3           2,838.6      2,575.1



          Income tax provision                                                                                              285.9      305.2             642.5        593.8



          
            Net Income                                                                                        $1,041.8   $1,025.1          $2,196.1     $1,981.3





          
            Net Income Attributable to Common Shareholders of                                                 $1,041.8   $1,012.2          $2,200.4     $1,956.4
CME Group - Basic(1)





          
            Net Income Attributable to Common Shareholders of                                                 $1,041.8   $1,012.2          $2,196.1     $1,956.4
CME Group - Diluted(1)





          
            Earnings per Share Attributable to Common
Shareholders of CME Group:



          Basic                                                                                                             $2.89      $2.81             $6.11        $5.44



          Diluted                                                                                                            2.88       2.81              6.06         5.43



          
            Weighted Average Number of Common Shares:



          Basic                                                                                                           360,684    359,658           360,005      359,636



          Diluted(2)                                                                                                      361,282    360,355           362,233      360,297




 1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.



 2. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.

                                    
          
         CME Group Inc. and Subsidiaries


                              
          
         Reconciliation of Adjusted Operating Income


                                                
       (dollars in millions)




                                                                                                          Quarter Ended                        Six Months Ended

                                                                                                          June 30,                        June 30,


                                                                                                 2026     2025             2026       2025



 
            Total Revenues                                                                $1,706.2 $1,692.0         $3,586.3   $3,334.3





 
            Adjusted Total Revenues                                                       $1,706.2 $1,692.0         $3,586.3   $3,334.3





 
            Total Expenses                                                                  $599.1   $562.7         $1,169.5   $1,097.0



 Restructuring and severance                                                                   (6.0)   (1.4)          (10.0)     (2.5)



 Deferred compensation(1)                                                                     (12.4)   (7.7)          (11.6)     (5.5)



 Amortization of purchased intangibles                                                        (56.0)  (56.2)         (112.1)   (111.3)



 Strategic transaction-related (costs) credits                                                 (1.0)   (2.8)           (1.6)     (2.8)



 Real estate-related (costs) credits                                                             0.7      8.1                        8.1



 Foreign exchange transaction gains (losses)                                                   (0.3)   (3.5)             0.6      (5.9)



 Unrealized and realized gains (losses) on assets                                                      (0.4)                     (0.4)



 Litigation matters or settlements                                                             (2.9)   (7.6)           (1.9)    (10.9)



 
            Adjusted Total Expenses                                                         $521.2   $491.2         $1,032.9     $965.8





 
            Operating Income                                                              $1,107.1 $1,129.3         $2,416.8   $2,237.3





 
            Adjusted Operating Income                                                     $1,185.0 $1,200.8         $2,553.4   $2,368.5




 1. Includes $12.4 million and $11.6 million for changes in our non-qualified deferred compensation liability in the second quarter and first six months of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income.

                                                   
          
            CME Group Inc. and Subsidiaries


                            
          
            Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share


                                       
          (dollars in millions, except per share amounts; shares in thousands)




                                                                                                                                     Quarter Ended                        Six Months Ended

                                                                                                                                     June 30,                        June 30,


                                                                                                                        2026         2025             2026      2025



          
            Net Income                                                                                  $1,041.8     $1,025.1         $2,196.1  $1,981.3



          Restructuring and severance                                                                                   6.0          1.4             10.0       2.5



          Amortization of purchased intangibles(1)                                                                     60.0         69.4            120.1     137.6



          Strategic transaction-related costs (credits)(2)                                                              0.3          2.8              0.4       2.8



          Real estate-related costs (credits)                                                                         (0.7)       (8.1)                    (8.1)



          Foreign exchange transaction (gains) losses                                                                   0.3          3.6            (0.6)      6.0



          Unrealized and realized (gains) losses on investments                                                       (3.9)                        19.0       6.4



          Unrealized and realized (gains) losses on assets                                                                          0.4                       0.4



          Litigation matters or settlements                                                                             2.9          7.6              1.9      10.9



          Income tax effect related to above                                                                         (15.3)      (15.5)          (36.3)   (31.6)



          Other income tax items(3)                                                                                   (9.7)       (7.3)           (8.8)    (8.9)



          
            Adjusted Net Income                                                                         $1,081.7     $1,079.4         $2,301.8  $2,099.3





          
            Adjusted Net Income Attributable to Common                                                  $1,081.7     $1,065.8         $2,305.6  $2,072.9
Shareholders of CME Group - Basic(4)





          
            Adjusted Net Income Attributable to Common                                                  $1,081.7     $1,065.8         $2,301.8  $2,072.9
Shareholders of CME Group - Diluted(4)





          
            Earnings per Share Attributable to Common Shareholders of CME Group:



               Basic                                                                                                  $2.89        $2.81            $6.11     $5.44



               Diluted                                                                                                 2.88         2.81             6.06      5.43





          
            Adjusted Earnings per Share Attributable to Common Shareholders of CME
Group:



               Basic                                                                                                  $3.00        $2.96            $6.40     $5.76



               Diluted                                                                                                 2.99         2.96             6.35      5.75





          
            Weighted Average Number of Common Shares:



               Basic                                                                                                360,684      359,658          360,005   359,636



               Diluted(5)                                                                                           361,282      360,355          362,233   360,297



  1. Includes $2.6 million and $5.2 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million and $2.8 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the second quarter and first six months of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.



 2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as that schedule does not include adjustment items or portions of items included in non-operating results.



 3. Other income tax items in the second quarter of 2026 include benefits related to the resolution of certain state income tax examinations and adjustments to tax reserves and tax receivables.



 4. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.



 5. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.

              
       
 CME Group Inc. and Subsidiaries


              
       
 Quarterly Operating Statistics




                2Q 2025                    3Q 2025      4Q 2025   1Q 2026    2Q 2026


 Trading Days        62                          64            64         61         62

                                    
   
         Quarterly Average Daily Volume (ADV)(1)


                                      
   
            CME Group ADV (in thousands)





   
            Product Line              2Q 2025                               3Q 2025  4Q 2025   1Q 2026    2Q 2026



   Interest rates                          15,472                                 13,378    13,010     18,674      14,532



   Equity indexes                           7,661                                  6,278     7,738      8,655       8,633



   Foreign exchange                         1,096                                    834       853      1,193         989



   Energy                                   3,082                                  2,295     2,523      3,985       2,667



   Agricultural commodities                 1,964                                  1,712     1,787      2,042       2,080



   Metals                                     943                                    825     1,441      1,682         941



   
            Total                      30,217                                 25,322    27,353     36,231      29,843


                              Venue

---


   CME Globex                              28,097                                 23,418    25,542     33,633      27,935



   Open outcry                                993                                    989       816      1,241         830



   Privately negotiated                     1,127                                    915       995      1,357       1,078



   
            Total                      30,217                                 25,322    27,353     36,231      29,843

                            
 
        Quarterly Average Rate Per Contract (RPC)(1)


                                
        
            CME Group RPC





 
            Product Line       2Q 2025                               3Q 2025     4Q 2025   1Q 2026    2Q 2026



 Interest rates                   $0.481                                 $0.487       $0.486     $0.457      $0.480



 Equity indexes                    0.635                                  0.652        0.611      0.597       0.605



 Foreign exchange                  0.772                                  0.841        0.847      0.780       0.813



 Energy                            1.138                                  1.214        1.245      1.084       1.131



 Agricultural commodities          1.435                                  1.423        1.427      1.344       1.426



 Metals                            1.456                                  1.505        1.295      1.153       1.315



 Average RPC                      $0.690                                 $0.702       $0.707     $0.652      $0.678




          1. ADV and RPC includes futures and options on futures only.

CME-G

View original content:https://www.prnewswire.com/news-releases/cme-group-inc-reports-strong-financial-results-for-q2-2026-302831456.html

SOURCE CME Group

Contact:

Media contact, Laurie Bischel, 312.648.8698, news@cmegroup.com, cmegroup.mediaroom.com, Investor contact, Adam Minick, 312.340.8365, investors@cmegroup.com

© 2026 Canjex Publishing Ltd. All rights reserved.